Literature DB >> 29283314

Delayed inhibition of tonic inhibition enhances functional recovery following experimental ischemic stroke.

James E Orfila1,2, Himmat Grewal1,2, Robert M Dietz2,3, Frank Strnad1,2, Takeru Shimizu1,2, Myriam Moreno1,2, Christian Schroeder1,2, Joan Yonchek1, Krista M Rodgers1, Andra Dingman3, Timothy J Bernard3, Nidia Quillinan1,2, Wendy B Macklin4, Richard J Traystman1,2,5, Paco S Herson1,2,5.   

Abstract

The current study focuses on the ability to improve cognitive function after stroke with interventions administered at delayed/chronic time points. In light of recent studies demonstrating delayed GABA antagonists improve motor function, we utilized electrophysiology, biochemistry and neurobehavioral methods to investigate the role of α5 GABAA receptors on hippocampal plasticity and functional recovery following ischemic stroke. Male C57Bl/6 mice were exposed to 45 min transient middle cerebral artery occlusion and analysis of synaptic and functional deficits performed 7 or 30 days after recovery. Our findings indicate that hippocampal long-term potentiation (LTP) is impaired 7 days after stroke and remain impaired for at least 30 days. We demonstrate that ex vivo administration of L655,708 reversed ischemia-induced plasticity deficits and importantly, in vivo administration at delayed time-points reversed stroke-induced memory deficits. Western blot analysis of hippocampal tissue reveals proteins responsible for GABA synthesis are upregulated (GAD65/67 and MAOB), increasing GABA in hippocampal interneurons 30 days after stroke. Thus, our data indicate that both synaptic plasticity and memory impairments observed after stroke are caused by excessive tonic GABA activity, making inhibition of specific GABA activity at delayed timepoints a potential therapeutic approach to improve functional recovery and reverse cognitive impairments after stroke.

Entities:  

Keywords:  Cognition and memory; GABAA receptors; hippocampus; stroke; synaptic plasticity

Mesh:

Substances:

Year:  2017        PMID: 29283314      PMCID: PMC6547193          DOI: 10.1177/0271678X17750761

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  23 in total

1.  Conjunctive representations, the hippocampus, and contextual fear conditioning.

Authors:  J W Rudy; R C O'Reilly
Journal:  Cogn Affect Behav Neurosci       Date:  2001-03       Impact factor: 3.282

Review 2.  The synaptic vesicle cycle.

Authors:  Thomas C Sudhof
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

3.  L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.

Authors:  John R Atack; Peter J Bayley; Guy R Seabrook; Keith A Wafford; Ruth M McKernan; Gerard R Dawson
Journal:  Neuropharmacology       Date:  2006-10-12       Impact factor: 5.250

4.  SK2 channels are neuroprotective for ischemia-induced neuronal cell death.

Authors:  Duane Allen; Shin Nakayama; Masayuki Kuroiwa; Takaaki Nakano; Julie Palmateer; Yasuharu Kosaka; Carmen Ballesteros; Masahiko Watanabe; Chris T Bond; Rafael Luján; James Maylie; John P Adelman; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-29       Impact factor: 6.200

5.  Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke.

Authors:  Jia Jia; Saurabh Verma; Shin Nakayama; Nidia Quillinan; Marjorie R Grafe; Patricia D Hurn; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-18       Impact factor: 6.200

Review 6.  Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates.

Authors:  Liselore Snaphaan; Frank-Erik de Leeuw
Journal:  Stroke       Date:  2006-12-07       Impact factor: 7.914

Review 7.  Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.

Authors:  Sarah T Pendlebury; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2009-09-24       Impact factor: 44.182

8.  Histopathological and behavioral characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice.

Authors:  Julia Kofler; Kimihiko Hattori; Masahiko Sawada; A Courtney DeVries; Lee J Martin; Patricia D Hurn; Richard J Traystman
Journal:  J Neurosci Methods       Date:  2004-06-15       Impact factor: 2.390

9.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.

Authors:  Andrew N Clarkson; Ben S Huang; Sarah E Macisaac; Istvan Mody; S Thomas Carmichael
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

10.  Perisynaptic GABA Receptors The Overzealous Protector.

Authors:  Andrew N Clarkson
Journal:  Adv Pharmacol Sci       Date:  2012-02-22
View more
  12 in total

1.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

2.  Transcranial Direct Current Stimulation Modulates GABA Levels Beyond the Stimulated Region: Perspectives for Stroke Rehabilitation.

Authors:  Takahiro Inoue; Kenji Taneda
Journal:  J Neurosci       Date:  2019-03-06       Impact factor: 6.167

3.  HIV gp120-induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK.

Authors:  Xinwen Zhang; Matthew V Green; Stanley A Thayer
Journal:  J Neurochem       Date:  2019-01-18       Impact factor: 5.372

4.  Reversal of Global Ischemia-Induced Cognitive Dysfunction by Delayed Inhibition of TRPM2 Ion Channels.

Authors:  Robert M Dietz; Ivelisse Cruz-Torres; James E Orfila; Olivia P Patsos; Kaori Shimizu; Nicholas Chalmers; Guiying Deng; Erika Tiemeier; Nidia Quillinan; Paco S Herson
Journal:  Transl Stroke Res       Date:  2019-06-28       Impact factor: 6.829

5.  Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells.

Authors:  Anisha D'Souza; Amelia Burch; Kandarp M Dave; Aravind Sreeram; Michael J Reynolds; Duncan X Dobbins; Yashika S Kamte; Wanzhu Zhao; Courtney Sabatelle; Gina M Joy; Vishal Soman; Uma R Chandran; Sruti S Shiva; Nidia Quillinan; Paco S Herson; Devika S Manickam
Journal:  J Control Release       Date:  2021-08-24       Impact factor: 11.467

6.  Juvenile cerebral ischemia reveals age-dependent BDNF-TrkB signaling changes: Novel mechanism of recovery and therapeutic intervention.

Authors:  Robert M Dietz; James E Orfila; Krista M Rodgers; Olivia P Patsos; Guiying Deng; Nicholas Chalmers; Nidia Quillinan; Richard J Traystman; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-03       Impact factor: 6.200

7.  Experimental pediatric stroke shows age-specific recovery of cognition and role of hippocampal Nogo-A receptor signaling.

Authors:  James E Orfila; Robert M Dietz; Krista M Rodgers; Andra Dingman; Olivia P Patsos; Ivelisse Cruz-Torres; Himmat Grewal; Frank Strnad; Christian Schroeder; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-14       Impact factor: 6.200

8.  The Gliopeptide ODN, a Ligand for the Benzodiazepine Site of GABAA Receptors, Boosts Functional Recovery after Stroke.

Authors:  Rhita Lamtahri; Mahmoud Hazime; Emma K Gowing; Raghavendra Y Nagaraja; Julie Maucotel; Michael Alasoadura; Pascale P Quilichini; Katia Lehongre; Benjamin Lefranc; Katarzyna Gach-Janczak; Ann-Britt Marcher; Susanne Mandrup; David Vaudry; Andrew N Clarkson; Jérôme Leprince; Julien Chuquet
Journal:  J Neurosci       Date:  2021-07-01       Impact factor: 6.167

9.  Hippocampal network dysfunction as a mechanism of early-onset dementia after preeclampsia and eclampsia.

Authors:  Abbie C Johnson; Zhaojin Li; James E Orfila; Paco S Herson; Marilyn J Cipolla
Journal:  Prog Neurobiol       Date:  2020-10-29       Impact factor: 11.685

Review 10.  Therapeutic Potential of Neurotrophins for Repair After Brain Injury: A Helping Hand From Biomaterials.

Authors:  Josh Houlton; Nashat Abumaria; Simon F R Hinkley; Andrew N Clarkson
Journal:  Front Neurosci       Date:  2019-08-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.